Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,489 | -16,609 | -7,019 | -16,925 | 237 |
| Depreciation Amortization | 912 | 1,038 | 1,102 | 1,076 | 773 |
| Accounts receivable | 149 | -150 | 9 | 261 | 560 |
| Accounts payable and accrued liabilities | -260 | -110 | -153 | 99 | 236 |
| Other Working Capital | 254 | -372 | 848 | -544 | 216 |
| Other Operating Activity | 1,015 | 2,110 | 2,450 | 2,335 | 479 |
| Operating Cash Flow | $-9,419 | $-14,093 | $-2,763 | $-13,698 | $2,501 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 50,238 | -30,000 |
| PPE Investments | -27 | -482 | -886 | -1,274 | -1,395 |
| Purchase Of Investment | N/A | -57 | N/A | -20,000 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -42 | -161 |
| Other Investing Activity | 0 | 0 | -270 | -42 | -161 |
| Investing Cash Flow | $-27 | $-539 | $-1,156 | $28,922 | $-31,556 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,102 | 9 | 1,108 | 1,874 | 38,760 |
| Financing Cash Flow | $3,102 | $9 | $1,108 | $1,874 | $38,760 |
| Exchange Rate Effect | 26 | -142 | -379 | -608 | 143 |
| Beginning Cash Position | 11,909 | 26,674 | 29,864 | 13,374 | 3,526 |
| End Cash Position | 5,591 | 11,909 | 26,674 | 29,864 | 13,374 |
| Net Cash Flow | $-6,318 | $-14,765 | $-3,190 | $16,490 | $9,848 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,419 | -14,093 | -2,763 | -13,698 | 2,501 |
| Capital Expenditure | -28 | -483 | -954 | -1,274 | -1,428 |
| Free Cash Flow | -9,447 | -14,576 | -3,717 | -14,972 | 1,073 |